Demo Sign up Log In

Vertex Pharmaceuticals (VRTX)

Total Costs & Expenses

$2.09B

Quarterly · Period ending: Jun 30, 2026 · USD

VRTX Total Costs & Expenses

Latest reported$2.09Bperiod endingJun 30, 2026

Latest reported$2.09Bperiod endingJun 30, 2026

VRTX Quarterly Total Costs & Expenses ($0.00 → $2.09B)

Quarterly Total Costs & Expenses

High-resolution chart · PNG

VRTX total costs & expenses history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Vertex Pharmaceuticals Total Costs & Expenses — Quarterly (USD)
Period ending	Total Costs & Expenses (USD)
Jun 30, 2001	38,891,000
Mar 31, 2001	34,452,000
Dec 31, 2000	34,105,000
Sep 30, 2000	29,038,000
Jun 30, 2000	27,582,000
Mar 31, 2000	26,084,000
Dec 31, 1999	27,500,000
Sep 30, 1999	23,500,000
Jun 30, 1999	25,700,000
Mar 31, 1999	24,400,000
Dec 31, 1998	24,000,000
Sep 30, 1998	20,500,000
Jun 30, 1998	16,800,000
Mar 31, 1998	15,500,000
Dec 31, 1997	17,700,000
Sep 30, 1997	19,200,000
Jun 30, 1997	13,400,000
Mar 31, 1997	12,500,000
Dec 31, 1996	10,300,000
Sep 30, 1996	10,300,000
Jun 30, 1996	11,400,000
Mar 31, 1996	11,100,000
Dec 31, 1995	10,500,000
Sep 30, 1995	10,300,000
Jun 30, 1995	16,800,000
Mar 31, 1995	11,000,000
Dec 31, 1994	11,100,000
Sep 30, 1994	10,300,000
Jun 30, 1994	10,200,000
Mar 31, 1994	8,800,000
Dec 31, 1993	9,400,000
Sep 30, 1993	7,300,000
Jun 30, 1993	5,600,000
Mar 31, 1993	4,400,000
Dec 31, 1992	3,900,000
Sep 30, 1992	3,600,000
Jun 30, 1992	3,300,000
Mar 31, 1992	3,000,000
Dec 31, 1991	2,500,000
Sep 30, 1991	2,200,000
Jun 30, 1991	2,100,000
Mar 31, 1991	0
Dec 31, 1990	-6,400,000
Sep 30, 1990	0
Jun 30, 1990	0
Mar 31, 1990	0

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.